Elevation of serum proprotein convertase subtilisin/kexin type 9 (PCSK9) concentrations and its possible atherogenic role in patients with systemic lupus erythematosus.

Fang, Chenglong; Luo, Tingting; Lin, Ling

Fang, Chenglong; Luo, Tingting; Lin, Ling.

Afiliación

Fang C; Department of Rheumatology, Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China.
Luo T; Department of Ultrasonic Cardiogram, Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China.
Lin L; Department of Rheumatology, Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China.

Ann Transl Med ; 6(23): 452, 2018 Dec.

Article en En | MEDLINE | ID: mdl-30603640

Palabras clave

Systemic lupus erythematosus (SLE); atherosclerosis; hydroxychloroquine (HCQ); inflammation; proprotein convertase subtilisin/kexin type 9 (PCSK9)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ann Transl Med Año: 2018 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google